Streetbeat News

Stock Prices

FGL

Founder Group is planning an IPO with an indicated price of $4.27 per share for 38,605 shares. This development could impact the market perception and valuation of the company.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 2:19 pm

LBGJ

Li Bang International's IPO shares are trading at $4.60, above the initial offering price of $4 per share. The IPO consists of 1.52 million shares, with 101,850 shares currently indicating the higher price.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 2:18 pm

BSX

Boston Scientific Corporation (NYSE:BSX) reported strong Q3 earnings, with revenues and EPS surpassing expectations. The company raised its annual forecast due to strong demand for heart devices. BSX's cardiovascular segment saw significant growth, and the company projects continued sales and EPS growth for 2024. Analysts have a positive outlook on BSX, with an average price target indicating potential upside.

Portfolio Pulse from Vandana Singh

October 23, 2024 | 2:16 pm

LLY

Eli Lilly has seen significant options activity, with a bullish sentiment from large investors. The options trades suggest a price range of $500 to $1260. Analysts have mixed ratings, with price targets ranging from $1025 to $1100. The stock is currently neutral with a slight decline.

Portfolio Pulse from Benzinga Insights

October 23, 2024 | 2:16 pm

HD

Financial giants have shown a bearish sentiment towards Home Depot (NYSE:HD) through unusual options activity, with 66% of trades being bearish. The predicted price range for HD is between $375 and $500. Despite this, analysts maintain positive ratings with target prices averaging $444. The stock is currently trading at $403.12, up by 0.32%, and may be approaching overbought territory.

Portfolio Pulse from Benzinga Insights

October 23, 2024 | 2:15 pm

RNST

Renasant shares are experiencing an uptick following the release of their Q3 financial results.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 2:15 pm

REGN

Deep-pocketed investors are showing a bearish sentiment towards Regeneron Pharmaceuticals (NASDAQ:REGN) through significant options activity. The options scanner at Benzinga highlighted 8 extraordinary options activities, with 50% of the sentiment being bearish. The stock is currently trading at $939.78, down by 2.34%, and analysts have mixed ratings with price targets ranging from $1050 to $1260.

Portfolio Pulse from Benzinga Insights

October 23, 2024 | 2:15 pm

LAD

Lithia Motors shares rose as the company reported Q3 adjusted EPS results that exceeded expectations.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 2:14 pm

VMI

Valmont Industries shares rose following the announcement of better-than-expected Q3 EPS results.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 2:13 pm

GD

General Dynamics Corp (NYSE:GD) reported a mixed Q3 fiscal 2024 performance with a 10.4% revenue increase to $11.671 billion, beating expectations. However, EPS of $3.35 fell short of the $3.53 consensus. Aerospace and Marine Systems led revenue gains, while Combat Systems saw a slight decline. The company maintained strong cash flow and a solid backlog, with a book-to-bill ratio of 1.1-to-1.

Portfolio Pulse from Akanksha Bakshi

October 23, 2024 | 2:13 pm